High plasma CCL2 concentrations have been shown to be associated with increased long-term risk of stroke [139,140], while CCL2 signaling pathways have been shown to be responsible for ischemic stroke progression and atrial fibrillation [141,142]. The gene discussed is CCL2; the disease is atrial fibrillation.